DOI QR코드

DOI QR Code

Enzymatic bioconversion of ginseng powder increases the content of minor ginsenosides and potentiates immunostimulatory activity

  • Park, Jisang (Innovative Research and Education Center for Integrated Bioactive Materials and the Department of Bioactive Material Sciences, Jeonbuk National University) ;
  • Kim, Ju (Department of Molecular Biology and the Institute for Molecular Biology and Genetics, Jeonbuk National University) ;
  • Ko, Eun-Sil (R&D Center, General Bio Co., Ltd.) ;
  • Jeong, Jong Hoon (R&D Center, General Bio Co., Ltd.) ;
  • Park, Cheol-Oh (R&D Center, General Bio Co., Ltd.) ;
  • Seo, Jeong Hun (R&D Center, General Bio Co., Ltd.) ;
  • Jang, Yong-Suk (Innovative Research and Education Center for Integrated Bioactive Materials and the Department of Bioactive Material Sciences, Jeonbuk National University)
  • Received : 2021.08.19
  • Accepted : 2021.12.14
  • Published : 2022.03.01

Abstract

Background: Ginsenosides are biologically active components of ginseng and have various functions. In this study, we investigated the immunomodulatory activity of a ginseng product generated from ginseng powder (GP) via enzymatic bioconversion. This product, General Bio compound K-10 mg solution (GBCK10S), exhibited increased levels of minor ginsenosides, including ginsenoside-F1, compound K, and compound Y. Methods: The immunomodulatory properties of GBCK10S were confirmed using mice and a human natural killer (NK) cell line. We monitored the expression of molecules involved in immune responses via enzyme-linked immunosorbent assay, flow cytometry, NK cell-targeted cell destruction, quantitative reverse-transcription real-time polymerase chain reaction, and Western blot analyses. Results: Oral administration of GBCK10S significantly increased serum immunoglobulin M levels and primed splenocytes to express pro-inflammatory cytokines such as interleukin-6, tumor necrosis factor-α, and interferon-γ. Oral administration of GBCK10S also activated NK cells in mice. Furthermore, GBCK10S treatment stimulated a human NK cell line in vitro, thereby increasing granzyme B gene expression and activating STAT5. Conclusion: GBCK10S may have potent immunostimulatory properties and can activate immune responses mediated by B cells, Th1-type T cells, and NK cells.

Keywords

Acknowledgement

This research was supported financially by the Ministry of Small and Medium-sized Enterprises (SMEs) and Startups (MSS), Korea, under the 'Regional Specialized Industry Development Plus Program (R&D, S3006097)', supervised by the Korea Institute for Advancement of Technology (KIAT). We thank Dr. C. Kim (Inha University, Incheon, Korea) for providing the YAC-I cell line. Dr. J. Park was supported by the BK21 FOUR program in the Department of Bioactive Material Sciences. Flow cytometry was performed using the instrument installed in the Center for University-Wide Research Facilities (CURF) at Jeonbuk National University.

References

  1. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  2. Baeg IH, So SH. The world ginseng market and the ginseng (Korea). J Ginseng Res 2013;37:1-7. https://doi.org/10.5142/jgr.2013.37.1
  3. Lee FC. Facts about ginseng. Elizabeth: Hollyn International Corp; 1992.
  4. Guclu-ustundag O, Mazza G. Saponins: properties, applications and processing. Crit Rev Food Sci Nutr 2007;47:231-58. https://doi.org/10.1080/10408390600698197
  5. Piao XM, Huo Y, Kang JP, Mathiyalagan R, Zhang H, Yang DU, et al. Diversity of ginsenoside profiles produced by various processing technologies. Molecules 2020;25:4390-409. https://doi.org/10.3390/molecules25194390
  6. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res 2021;45:199-210. https://doi.org/10.1016/j.jgr.2020.02.004
  7. Sharma A, Lee HJ. Ginsenoside compound K: insights into recent studies on pharmacokinetics and health-promoting activities. Biomolecules 2020;10:1028-68. https://doi.org/10.3390/biom10071028
  8. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003;31:1065-71. https://doi.org/10.1124/dmd.31.8.1065
  9. Kim DH. Gut microbiota-mediated pharmacokinetics of ginseng saponins. J Ginseng Res 2018;42:255-63. https://doi.org/10.1016/j.jgr.2017.04.011
  10. Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009:143-8.
  11. Park SY, Bae EA, Sung JH, Lee SK, Kim DH. Purification and characterization of ginsenoside Rb1-metabolizing b-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci Biotechnol Biochem 2001;65:1163-9. https://doi.org/10.1271/bbb.65.1163
  12. Quan K, Liu Q, Wan JY, Zhao YJ, Guo RZ, Alolga RN, et al. Rapid preparation of rare ginsenosides by acid transformation and their structureeactivity relationships against cancer cells. Sci Rep 2015;5:8598-604. https://doi.org/10.1038/srep08598
  13. Park H. The role of gut microbiota in ginsenoside metabolism and biotransformation of ginsenoside by lactic acid bacteria. Curr Top Lact Acid Bact Probiotics 2019;5:1-12. https://doi.org/10.35732/ctlabp.2019.5.1.1
  14. Jang SH, Oh MS, Baek HI, Ha KC, Lee JY, Jang YS. Oral administration of silk peptide enhances the maturation and cytolytic activity of natural killer cells. Immune Netw 2018;18:37-50.
  15. Jang SH, Oh MS, Baek HI, Ha KC, Lee JY, Jang YS. Silk peptide treatment potentiates natural killer cell activity in vitro and induces natural killer cell maturation and activation in mouse splenocytes. Pharm Biol 2019;57:369-79. https://doi.org/10.1080/13880209.2019.1617749
  16. Park J, Seo KW, Kim SH, Lee HY, Kim B, Lim CW, et al. Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model. Vet Microbiol 2015;177:142-53. https://doi.org/10.1016/j.vetmic.2015.03.005
  17. Park J, Lee HY, Khai LT, Thuy NTT, Mai LQ, Jang YS. Addition of partial envelope domain II into envelope domain III of dengue virus antigen potentiates the induction of virus-neutralizing antibodies and induces protective immunity. Vaccines 2020;15:88-103.
  18. Lee JY, Bae S, Myoung J. Middle East respiratory syndrome coronavirus-encoded accessory proteins impair MDA5-and TBK1-mediated activation of NF-κB. J Microbiol Biotechnol 2019;29:1316-23. https://doi.org/10.4014/jmb.1908.08004
  19. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5. https://doi.org/10.1038/nmeth.2089
  20. Li W, Gu C, Zhang H, Awang DVC, Fitzloff JF, Fong HHS, et al. Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Anal Chem 2000;72:5417-22. https://doi.org/10.1021/ac000650l
  21. Yoo D-S, Rho H-S, Lee Y-G, Yeom M-H, Kim D-H, Lee S-J, et al. Ginsenoside F1 modulates cellular responses of skin melanoma cells. J Ginseng Res 2011;35:86-91. https://doi.org/10.5142/jgr.2011.35.1.086
  22. Kwon HJ, Lee H, Choi GE, Kwon SJ, Song AY, Kim SJ, et al. Ginsenoside F1 promotes cytotoxic activity of NK cells via insulin-like growth factor-1-dependent mechanism. Front Immunol 2018;9:2785-98. https://doi.org/10.3389/fimmu.2018.02785
  23. Kang S, Min H. Ginseng, the "immunity boost": the effects of Panax ginseng on immune system. J Ginseng Res 2012;36:354-68. https://doi.org/10.5142/jgr.2012.36.4.354
  24. Iizuka K, Naidenko OV, Plougastel BFM, Fremont DH, Yokoyama WM. Genetically linked C-typed lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 2003;4:801-7. https://doi.org/10.1038/ni954
  25. Kuroki K, Furukawa A, Maenaka K. Molecular recognition of paired receptors in the immune system. Front Microbiol 2012;3:429-40. https://doi.org/10.3389/fmicb.2012.00429
  26. Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front Immunol 2018;9:1869-91. https://doi.org/10.3389/fimmu.2018.01869
  27. Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, et al. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res 2006;66:7317-25. https://doi.org/10.1158/0008-5472.CAN-06-0680
  28. Nandagopal N, Ali AK, Komal AK, Lee SH. The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions. Front Immunol 2014;5(187):1-12.
  29. Gotthardt D, Sexl V. STATs in NK-cells: the good, the bad, and the ugly. Front Immunol 2017;7:694-701. https://doi.org/10.3389/fimmu.2016.00694
  30. Tanaka T, Narazaki M, Kishimoto T. Il-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspect Biol 2014;6:a016295. https://doi.org/10.1101/cshperspect.a016295
  31. Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, et al. CD8+ T cells, NK cells and IFN-γ are important for control of tumor with down-regulated MHC class I expression by DNA vaccination. Gene Ther 2003;10:1311-20. https://doi.org/10.1038/sj.gt.3301982
  32. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009;113:5488-96. https://doi.org/10.1182/blood-2008-10-187179
  33. Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell response. Trends Immunol 2013;34:342-9. https://doi.org/10.1016/j.it.2013.03.002
  34. Gotthardt D, Putz EM, Grundschober E, Prchal-Murphy M, Straka E, Kudweis P, et al. STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion. Cancer Discov 2016;6:414-29. https://doi.org/10.1158/2159-8290.CD-15-0732
  35. Zhang X, Zhang S, Sun Q, Jiao W, Yan Y, Zhang X. Compound K induces endoplasmic reticulum stress and apoptosis in human liver cancer cells by regulating STAT3. Molecules 2018;23:1482-97. https://doi.org/10.3390/molecules23061482